KR930701175A - 인체 전립선 아데노카르시노마의 치료방법 - Google Patents
인체 전립선 아데노카르시노마의 치료방법Info
- Publication number
- KR930701175A KR930701175A KR1019920703380A KR920703380A KR930701175A KR 930701175 A KR930701175 A KR 930701175A KR 1019920703380 A KR1019920703380 A KR 1019920703380A KR 920703380 A KR920703380 A KR 920703380A KR 930701175 A KR930701175 A KR 930701175A
- Authority
- KR
- South Korea
- Prior art keywords
- treat
- human prostate
- prostate adenocarcinoma
- alpha
- reductase inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/544,709 US5300294A (en) | 1990-06-27 | 1990-06-27 | Method of treating prostatic adenocarcinoma |
US544709 | 1990-06-27 | ||
PCT/US1991/004508 WO1992000010A1 (en) | 1990-06-27 | 1991-06-21 | Method of treating human prostatic adenocarcinoma |
Publications (2)
Publication Number | Publication Date |
---|---|
KR930701175A true KR930701175A (ko) | 1993-06-11 |
KR100209825B1 KR100209825B1 (ko) | 1999-07-15 |
Family
ID=24173248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920703380A KR100209825B1 (ko) | 1990-06-27 | 1991-06-21 | 인체 전립선 아데노카르시노마의 치료용 약제조성물 |
Country Status (15)
Country | Link |
---|---|
US (2) | US5300294A (ko) |
EP (1) | EP0536282B1 (ko) |
JP (5) | JP2702280B2 (ko) |
KR (1) | KR100209825B1 (ko) |
AT (1) | ATE151635T1 (ko) |
AU (1) | AU650033B2 (ko) |
CA (1) | CA2084775C (ko) |
DE (1) | DE69125714T2 (ko) |
DK (1) | DK0536282T3 (ko) |
ES (1) | ES2100952T3 (ko) |
GR (1) | GR3024064T3 (ko) |
HK (1) | HK1006412A1 (ko) |
IE (1) | IE81134B1 (ko) |
WO (1) | WO1992000010A1 (ko) |
ZA (1) | ZA914919B (ko) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5300294A (en) * | 1990-06-27 | 1994-04-05 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
CA2084799C (en) | 1991-12-17 | 2003-01-28 | Glenn J. Gormley | Method of prevention of prostatic carcinoma with 17 beta-n-monosubstituted-carbamoyl-4-aza-5 alpha-androst-1 -en-3-ones |
US5994362A (en) * | 1992-03-11 | 1999-11-30 | Merck & Co., Inc. | Method of treatment for prostatic cancer |
US5710275A (en) * | 1992-05-20 | 1998-01-20 | Merck & Co., Inc. | 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors |
CA2135167A1 (en) * | 1992-05-20 | 1993-11-25 | Donald W. Graham | New 17-ester, amide, and ketone derivatives of 3-oxo-4- azasteroids as 5a-reductase inhibitors |
GB9210880D0 (en) * | 1992-05-21 | 1992-07-08 | Smithkline Beecham Corp | Compounds |
GB9213901D0 (en) * | 1992-06-30 | 1992-08-12 | Smithkline Beecham Corp | Compounds |
CN1133005A (zh) * | 1993-09-03 | 1996-10-09 | 史密丝克莱恩比彻姆公司 | 稳定的片剂 |
US5763490A (en) * | 1994-09-20 | 1998-06-09 | University Of South Carolina | Treating prostate cancer with tartrate ions |
US5578724A (en) * | 1994-09-20 | 1996-11-26 | Eli Lilly And Company | Process for preparation of benzo[f]quinolinones |
US5629007A (en) * | 1995-03-21 | 1997-05-13 | Eli Lilly And Company | Method of preventing prostatic cancer development |
US5635197A (en) * | 1995-03-21 | 1997-06-03 | Eli Lilly And Company | Treatment and prevention of prostatic cancer metastasis |
JPH09172979A (ja) * | 1995-12-27 | 1997-07-08 | Ajinomoto Co Inc | 新規リン酸アミノ酸複合塩及び制酸剤を含有する反すう動物用飼料添加組成物 |
US6093722A (en) | 1997-02-26 | 2000-07-25 | Sankyo Company, Limited | Method for treating prostate cancer |
GB9717444D0 (en) * | 1997-08-19 | 1997-10-22 | Glaxo Group Ltd | Pharmaceutical composition |
US5994335A (en) | 1997-10-17 | 1999-11-30 | The University Of Maryland, Baltimore | 17-azolyl steroids useful as androgen synthesis inhibitors |
US6365181B1 (en) | 2000-04-20 | 2002-04-02 | Gattefosse Corporation | Thixatropic gelatin carrier composition |
US20060084704A1 (en) * | 2004-01-28 | 2006-04-20 | Charles Shih | Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof |
JP2007526913A (ja) * | 2004-01-28 | 2007-09-20 | アンドロサイエンス コーポレイション | ステロイド依存性の遺伝子活性化経路の異なる段階を標的とする阻害剤の組み合わせによる抗アンドロゲン活性の増強およびその使用 |
US20100047338A1 (en) | 2008-03-14 | 2010-02-25 | Angela Brodie | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
AU2008205312B2 (en) | 2007-01-08 | 2013-11-21 | Annji Pharmaceutical Co., Ltd. | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof |
US8710272B2 (en) | 2007-01-08 | 2014-04-29 | Androscience Corporation | Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof |
US9000222B2 (en) | 2007-01-08 | 2015-04-07 | Androscience Corporation | Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof |
EP2175726A4 (en) | 2007-07-31 | 2011-01-05 | Androscience Corp | COMPOSITIONS WITH ANDROGEN RECEPTOR DERIVATIVES AND METHOD FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF SKIN DISEASES OR HAIR LOSS |
JP2012516900A (ja) | 2009-02-05 | 2012-07-26 | トーカイ ファーマシューティカルズ,インク. | ステロイド性cyp17阻害剤/抗アンドロゲン剤の新しいプロドラッグ |
WO2014153215A1 (en) | 2013-03-14 | 2014-09-25 | University Of Maryland,Baltimore Office Of Technology Transfer | Androgen receptor down-regulating agents and uses thereof |
AU2014306698A1 (en) | 2013-08-12 | 2016-01-28 | Tokai Pharmaceuticals, Inc. | Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies |
US10585101B2 (en) | 2016-03-10 | 2020-03-10 | Wavesense, Inc. | Prostatic liquid biopsy for the detection of prostate cancer and benign prostatic hyperplasia |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU527030B2 (en) * | 1978-04-13 | 1983-02-10 | Merck & Co., Inc. | 4-aza-17-substituted-5a-androstan-3-ones |
US5049562A (en) * | 1984-02-27 | 1991-09-17 | Merck & Co., Inc. | 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors |
GB8505862D0 (en) * | 1985-03-07 | 1985-04-11 | Erba Farmitalia | Steroidic 5alpha-reductase inhibitors |
JPS63203625A (ja) * | 1987-02-19 | 1988-08-23 | Kao Corp | 5α−リダクタ−ゼ阻害剤 |
DE3888378T2 (de) * | 1987-04-03 | 1994-09-29 | Merck & Co Inc | Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen. |
US4910226A (en) * | 1987-04-29 | 1990-03-20 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
ZA883034B (en) * | 1987-04-29 | 1989-03-29 | Smithkline Beckman Corp | Steroid 5-alpha-reductase inhibitors |
US5041433A (en) * | 1987-04-29 | 1991-08-20 | Smithkline Beecham Corporation | 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase |
US4946834A (en) * | 1988-12-23 | 1990-08-07 | Smithkline Beecham Corporation | Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors |
US4882319A (en) * | 1988-12-23 | 1989-11-21 | Smithkline Beckman Corporation | Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase |
US4937237A (en) * | 1988-12-23 | 1990-06-26 | Smithkline Beckman Corporation | Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase |
US4970205A (en) * | 1988-12-23 | 1990-11-13 | Smithkline Beecham Corporation | Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase |
DK0595796T3 (da) * | 1989-07-07 | 2003-05-05 | Endorech Inc | Fremgangsmåde til behandling af androgen-relaterede sygdomme |
CA2023157A1 (en) * | 1989-08-21 | 1991-02-22 | Gary H. Rasmusson | 17 beta-acyl-4-aza-5 alpha-androst-1-ene-3-ones as 5 alpha-reductase inhibitors |
US5032586A (en) * | 1989-08-24 | 1991-07-16 | Smithkline Beecham Corporation | 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase |
US5137882A (en) * | 1990-06-11 | 1992-08-11 | Holt Dennis A | Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors |
US5300294A (en) * | 1990-06-27 | 1994-04-05 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
-
1990
- 1990-06-27 US US07/544,709 patent/US5300294A/en not_active Expired - Fee Related
-
1991
- 1991-06-21 JP JP3512105A patent/JP2702280B2/ja not_active Expired - Fee Related
- 1991-06-21 CA CA002084775A patent/CA2084775C/en not_active Expired - Fee Related
- 1991-06-21 DE DE69125714T patent/DE69125714T2/de not_active Revoked
- 1991-06-21 EP EP91912759A patent/EP0536282B1/en not_active Revoked
- 1991-06-21 WO PCT/US1991/004508 patent/WO1992000010A1/en not_active Application Discontinuation
- 1991-06-21 ES ES91912759T patent/ES2100952T3/es not_active Expired - Lifetime
- 1991-06-21 DK DK91912759.7T patent/DK0536282T3/da active
- 1991-06-21 KR KR1019920703380A patent/KR100209825B1/ko not_active IP Right Cessation
- 1991-06-21 AT AT91912759T patent/ATE151635T1/de not_active IP Right Cessation
- 1991-06-21 AU AU82076/91A patent/AU650033B2/en not_active Ceased
- 1991-06-26 ZA ZA914919A patent/ZA914919B/xx unknown
- 1991-06-26 IE IE223391A patent/IE81134B1/en not_active IP Right Cessation
-
1993
- 1993-12-20 US US08/170,481 patent/US5496556A/en not_active Expired - Lifetime
-
1997
- 1997-06-18 JP JP9161413A patent/JPH1081625A/ja active Pending
- 1997-07-09 GR GR970401720T patent/GR3024064T3/el unknown
-
1998
- 1998-06-18 HK HK98105681A patent/HK1006412A1/xx not_active IP Right Cessation
-
2000
- 2000-04-12 JP JP2000110771A patent/JP2000309536A/ja active Pending
-
2002
- 2002-03-11 JP JP2002065181A patent/JP2002308776A/ja not_active Withdrawn
-
2006
- 2006-12-13 JP JP2006336003A patent/JP2007063296A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
GR3024064T3 (en) | 1997-10-31 |
JP2007063296A (ja) | 2007-03-15 |
ZA914919B (en) | 1992-07-29 |
US5496556A (en) | 1996-03-05 |
ATE151635T1 (de) | 1997-05-15 |
JP2002308776A (ja) | 2002-10-23 |
DE69125714D1 (de) | 1997-05-22 |
JP2702280B2 (ja) | 1998-01-21 |
WO1992000010A1 (en) | 1992-01-09 |
EP0536282A4 (en) | 1993-05-05 |
US5300294A (en) | 1994-04-05 |
JPH05508155A (ja) | 1993-11-18 |
EP0536282A1 (en) | 1993-04-14 |
IE81134B1 (en) | 2000-03-22 |
JPH1081625A (ja) | 1998-03-31 |
KR100209825B1 (ko) | 1999-07-15 |
ES2100952T3 (es) | 1997-07-01 |
JP2000309536A (ja) | 2000-11-07 |
EP0536282B1 (en) | 1997-04-16 |
HK1006412A1 (en) | 1999-02-26 |
CA2084775A1 (en) | 1991-12-28 |
DK0536282T3 (da) | 1997-10-27 |
DE69125714T2 (de) | 1997-10-23 |
AU8207691A (en) | 1992-01-23 |
IE912233A1 (en) | 1992-01-01 |
CA2084775C (en) | 2003-04-15 |
AU650033B2 (en) | 1994-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930701175A (ko) | 인체 전립선 아데노카르시노마의 치료방법 | |
DK1203770T3 (da) | Pyran-2-oner og 5,6-dihydropyran-2-oner, der er nyttige til behandling af hyperplasi og andre sygdomme | |
SE8104624L (sv) | Anvendning av kombinationen av en aromatashemmare med ett antindrogent medel for profylax och terapi av prostatahyperaplasi | |
ES2019942B3 (es) | Tratamiento de formaciones subterraneas que contienen hierro. | |
EP0667769A4 (en) | USE OF SPECIFIC ALPHA-1C COMPOUNDS IN THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA. | |
NO20044458L (no) | Anvendelse av en ringsystemforbindelse for fremstilling av et medikament | |
SE7813276L (sv) | Forfarande for deodorisering av slam, speciellt avloppsslam | |
ES2118414T3 (es) | Utilizacion de derivados del indolocarbazol para el tratamiento de la prostata. | |
DK0724592T3 (da) | 16-substitueret-4-aza-androstan-5alfa-reduktaseisozym-1-inhibitorer | |
ZA871860B (en) | Transglutaminase inhibitors | |
ES2105774T3 (es) | Procedimiento de tratamiento de la alopecia androgena con inhibidores de la 5-alfa reductasa. | |
FI820115L (fi) | Tetrahydronaftalen- och indanfoereningar | |
DE69218200D1 (de) | Behandlung von leberkrebs | |
ID26965A (id) | Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid | |
TW366338B (en) | Arylalkoxyphenoxy-imidazoline compounds | |
JPS53142044A (en) | Method of treating drainage | |
JPS5434552A (en) | Method of treating excess sludge | |
SU747106A1 (ru) | Способ огневой проработки канала | |
ES2120573T3 (es) | 24-epi-1-alfa-hidroxivitamina d2 para tratar la osteoporosis. | |
ES218755U (es) | Mampara decorativa para baños. | |
JPS53114254A (en) | Method for biological denitrification of night soil waste water | |
JPS5411036A (en) | Gold-plated wristwatch cash |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20080331 Year of fee payment: 10 |
|
LAPS | Lapse due to unpaid annual fee |